Immunodeficiency
Immunodeficiency disorders impair the immune system's ability to defend against infections and diseases, resulting from genetic defects (primary immunodeficiencies) or acquired conditions (secondary immunodeficiencies). Primary immunodeficiencies affect immune cell development, function, or signaling pathways, leading to recurrent infections, opportunistic infections, and increased susceptibility to autoimmune diseases or cancers. Secondary immunodeficiencies can arise from infections, medications (e.g., chemotherapy), malnutrition, or aging, compromising immune responses and overall health. Management includes immunoglobulin replacement therapy, antimicrobial prophylaxis, and stem cell transplantation to restore immune function and improve quality of life for patients with immunodeficiency disorders.
Related Conference of Immunodeficiency
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
Immunodeficiency Conference Speakers
Recommended Sessions
- Immunology
- Pediatrics Immunology
- Cancer Immunology and Immunotherapy
- Diagnostic and Technological Novelty of Immunology
- Epidemiology
- Immune System
- Immunodeficiency
- Immunogenetics
- Immunoinformatics & Systems Immunology
- Immunological Techniques
- Immunotherapy
- Immunotoxicology
- Neuroimmunology
- Parasite Immunology
- Reproductive Immunology
- Transplantation Immunology
- Viral Immunology
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Cancer Immunology and Immunotherapy - European Immunology 2025 (Italy)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Diagnostic and Technological Novelty of Immunology - European Immunology 2025 (Italy)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Epidemiology - European Immunology 2025 (Italy)
- Immune System - European Immunology 2025 (Italy)
- Immunodeficiency - European Immunology 2025 (Italy)
- Immunogenetics - European Immunology 2025 (Italy)
- Immunoinformatics & Systems Immunology - European Immunology 2025 (Italy)
- Immunological Techniques - European Immunology 2025 (Italy)
- Immunology - European Immunology 2025 (Italy)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Immunotherapy - European Immunology 2025 (Italy)
- Immunotoxicology - European Immunology 2025 (Italy)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Neuroimmunology - European Immunology 2025 (Italy)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Parasite Immunology - European Immunology 2025 (Italy)
- Pediatrics Immunology - European Immunology 2025 (Italy)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- Reproductive Immunology - European Immunology 2025 (Italy)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)
- Transplantation Immunology - European Immunology 2025 (Italy)
- Viral Immunology - European Immunology 2025 (Italy)